aciclovir 4

On Monday, federal officials announced they are seeking to establish a national coverage policy for aducanumab (Aduhelm) for Alzheimer’s disease (AD), a process that will take until next year to complete. The Centers for Medicare & Medicaid Services (CMS) said it will accept public comments about how Medicare should cover aducanumab through August 11. The agency intends to post a […]
» Read more